Galina Salogub

838 total citations
18 papers, 280 citations indexed

About

Galina Salogub is a scholar working on Hematology, Physiology and Molecular Biology. According to data from OpenAlex, Galina Salogub has authored 18 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Galina Salogub's work include Lysosomal Storage Disorders Research (5 papers), Cellular transport and secretion (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Galina Salogub is often cited by papers focused on Lysosomal Storage Disorders Research (5 papers), Cellular transport and secretion (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Galina Salogub collaborates with scholars based in Russia, United States and Greece. Galina Salogub's co-authors include Matthew L. Sherman, Abdulkadyrov Km, Evangelos Terpos, Shankar Srinivasan, Abderrahmane Laadem, Robert Knight, С. Н. Пчелина, Михаил Николаев, Ekaterina Zakharova and Anton Emelyanov and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Galina Salogub

18 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Galina Salogub Russia 8 98 96 94 79 58 18 280
Piero Pignataro Italy 10 99 1.0× 63 0.7× 48 0.5× 155 2.0× 137 2.4× 14 379
Haig Inguilizian United States 5 62 0.6× 83 0.9× 47 0.5× 190 2.4× 14 0.2× 5 329
Judit Várkonyi Hungary 12 82 0.8× 50 0.5× 241 2.6× 121 1.5× 41 0.7× 39 483
Shinya Rai Japan 11 34 0.3× 71 0.7× 106 1.1× 128 1.6× 23 0.4× 47 385
Pak Leng Cheong Australia 8 38 0.4× 28 0.3× 84 0.9× 148 1.9× 30 0.5× 17 321
Anne Maitland United States 6 32 0.3× 100 1.0× 23 0.2× 51 0.6× 16 0.3× 12 338
Monika Haubitz Switzerland 8 46 0.5× 41 0.4× 24 0.3× 159 2.0× 19 0.3× 12 236
Barbara A. Kosciolek United States 10 82 0.8× 18 0.2× 76 0.8× 131 1.7× 123 2.1× 14 349
Yota Sato Japan 11 28 0.3× 214 2.2× 17 0.2× 88 1.1× 16 0.3× 35 419
Rebecca H. Horton United Kingdom 4 21 0.2× 46 0.5× 77 0.8× 182 2.3× 7 0.1× 8 295

Countries citing papers authored by Galina Salogub

Since Specialization
Citations

This map shows the geographic impact of Galina Salogub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galina Salogub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galina Salogub more than expected).

Fields of papers citing papers by Galina Salogub

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galina Salogub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galina Salogub. The network helps show where Galina Salogub may publish in the future.

Co-authorship network of co-authors of Galina Salogub

This figure shows the co-authorship network connecting the top 25 collaborators of Galina Salogub. A scholar is included among the top collaborators of Galina Salogub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galina Salogub. Galina Salogub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Григорьева, Е. В., Михаил Николаев, Farid M. Ibatullin, et al.. (2023). Potential Binding Sites of Pharmacological Chaperone NCGC00241607 on Mutant β-Glucocerebrosidase and Its Efficacy on Patient-Derived Cell Cultures in Gaucher and Parkinson’s Disease. International Journal of Molecular Sciences. 24(10). 9105–9105. 8 indexed citations
2.
Ulrikh, Е. A., et al.. (2022). Personalized treatment of malignant tumors during pregnancy. Medicine. 101(26). e29803–e29803. 1 indexed citations
3.
Николаев, Михаил, Galina Baydakova, Konstantin Senkevich, et al.. (2021). Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism. Parkinsonism & Related Disorders. 84. 112–121. 43 indexed citations
4.
Семочкин, С. В., et al.. (2019). Practical Aspects of the Use of Carfilzomib in Multiple Myeloma. SHILAP Revista de lepidopterología. 12(1). 21–31. 1 indexed citations
6.
Voloshin, Sergey, et al.. (2019). Role of molecular-genetic abnormalities in pathogenesis and risk stratification of multiple myeloma.. PubMed. 62(4). 429–38. 1 indexed citations
7.
Николаев, Михаил, Anton Emelyanov, Galina Salogub, et al.. (2019). Human Peripheral Blood Macrophages As a Model for Studying Glucocerebrosidase Dysfunction. Cell and Tissue Biology. 13(2). 100–106. 10 indexed citations
8.
Salogub, Galina, et al.. (2018). Clinical case of treatment of patient with aHUS in obstetrical practice. Experience of anesthesiology and resuscitation department. Annals of critical care. 87–94. 1 indexed citations
9.
Алифирова, В. М., М. Н. Захарова, Elena Zakharova, et al.. (2017). Clinical recommendations on the use of alemtuzumab (lemtrada). S S Korsakov Journal of Neurology and Psychiatry. 117(2. Vyp. 2). 115–115. 7 indexed citations
10.
Baykov, Vadim, et al.. (2015). Rare Form of Erdheim-Chester Disease Presenting with Isolated Central Skeletal Lesions Treated with a Combination of Alfa-Interferon and Zoledronic Acid. SHILAP Revista de lepidopterología. 2015. 1–4. 8 indexed citations
11.
Пчелина, С. Н., et al.. (2014). Increased plasma oligomeric alpha-synuclein in patients with lysosomal storage diseases. Neuroscience Letters. 583. 188–193. 36 indexed citations
12.
Km, Abdulkadyrov, Galina Salogub, Matthew L. Sherman, et al.. (2014). Sotatercept in patients with osteolytic lesions of multiple myeloma. British Journal of Haematology. 165(6). 814–823. 103 indexed citations
13.
Salogub, Galina, et al.. (2009). Нейротоксичность бортезомиба в лечении множественной миеломы: опыт одного центра и обзор литературы. Oncohematology. 1 indexed citations
15.
Smith, Deborah A., Thomas E. Boyd, Donald Richards, et al.. (2009). Single-agent activity of GCS-100, a first-in-class galectin-3 antagonist, in elderly patients with relapsed chronic lymphocytic leukemia. Journal of Clinical Oncology. 27(15_suppl). 7006–7006. 20 indexed citations
17.
Salogub, Galina, et al.. (1997). Interphase ribosomal RNA cistron silver staining in refractory anaemias with and without excess blasts.. Molecular Pathology. 50(2). 92–95. 3 indexed citations
18.
Salogub, Galina, et al.. (1995). Interphase ribosomal RNA cistron staining in chronic myeloid leukaemia. Molecular Pathology. 48(5). M260–M263. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026